PD 113270
PD 113270 (CL 1565-B) is an antitumor agent. PD 113270 exhibits inhibitory effects to yeasts[1].
Product Specifications
CAS Number
87860-37-5
Product Name Alternative
CL 1565-B
UNSPSC
12352005
Target
Fungal
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/pd-113270.html
Solubility
10 mM in DMSO
Smiles
O=C1C=CC[C@H](/C=C/[C@@](C)(O)[C@H](OP(O)(O)=O)C[C@@H](O)/C=C\C=C/C=C/C)O1
Molecular Formula
C19H27O8P
Molecular Weight
414.39
References & Citations
[1]Tunac J B, et, al. Novel antitumor agents CI-920, PD 113,270 and PD 113,271. I. Taxonomy, fermentation and biological properties. J Antibiot (Tokyo) . 1983 Dec;36 (12) :1595-600.|[2]Mamber SW, et, al. Antimycotic effects of the novel antitumor agents fostriecin (CI-920), PD 113,270 and PD 113,271. J Antibiot (Tokyo) . 1986 Oct;39 (10) :1467-72.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6414681-01 0.1 mL
DRG2 (N-myc Downstream-Regulated Gene 2 Protein) (PE)
Sign In for Pricing
View Details MBS6414681-02 5x 0.1 mL
DRG2 (N-myc Downstream-Regulated Gene 2 Protein) (PE)
Sign In for Pricing
View Details 
134269-ML405 100 µL
TBX6 (T-box Transcription Factor TBX6, T-box Protein 6) (MaxLight 405) discontinued
Sign In for Pricing
View Details